ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: While non-coding RNAs can affect almost all steps in resistance mechanism, regulation of expression of MDR proteins seems to be among the most important BCR/ABL1-independent mechanisms of imatinib resistance in CML (Fig. 1).